The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Gadolinium-Based Contrast Agents Market Research Report 2025
Synopsis
Contrast Agents for MRI
The global Gadolinium-Based Contrast Agents market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Gadolinium-Based Contrast Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Gadolinium-Based Contrast Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Gadolinium-Based Contrast Agents include GE Healthcare, Bayer, Bracco Imaging, Guerbet Group, Hengrui Medicine, Lantheus, YRPG, BeiLu Pharma and Jiangsu Hengrui Medicine, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Gadolinium-Based Contrast Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gadolinium-Based Contrast Agents.
Report Scope
The Gadolinium-Based Contrast Agents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gadolinium-Based Contrast Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gadolinium-Based Contrast Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GE Healthcare
Bayer
Bracco Imaging
Guerbet Group
Hengrui Medicine
Lantheus
YRPG
BeiLu Pharma
Jiangsu Hengrui Medicine
Marotrast
Agfa
Stary
Segment by Type
Linear Gadolinium-Based Contrast Agents
Macrocycle Gadolinium-Based Contrast Agents
Segment by Application
Hospital
Specialist Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gadolinium-Based Contrast Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gadolinium-Based Contrast Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Contrast Agents for MRI
The global Gadolinium-Based Contrast Agents market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Gadolinium-Based Contrast Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Gadolinium-Based Contrast Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Gadolinium-Based Contrast Agents include GE Healthcare, Bayer, Bracco Imaging, Guerbet Group, Hengrui Medicine, Lantheus, YRPG, BeiLu Pharma and Jiangsu Hengrui Medicine, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Gadolinium-Based Contrast Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gadolinium-Based Contrast Agents.
Report Scope
The Gadolinium-Based Contrast Agents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gadolinium-Based Contrast Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gadolinium-Based Contrast Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GE Healthcare
Bayer
Bracco Imaging
Guerbet Group
Hengrui Medicine
Lantheus
YRPG
BeiLu Pharma
Jiangsu Hengrui Medicine
Marotrast
Agfa
Stary
Segment by Type
Linear Gadolinium-Based Contrast Agents
Macrocycle Gadolinium-Based Contrast Agents
Segment by Application
Hospital
Specialist Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gadolinium-Based Contrast Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gadolinium-Based Contrast Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Gadolinium-Based Contrast Agents Market Overview
1.1 Product Overview and Scope of Gadolinium-Based Contrast Agents
1.2 Gadolinium-Based Contrast Agents Segment by Type
1.2.1 Global Gadolinium-Based Contrast Agents Market Value Comparison by Type (2024-2030)
1.2.2 Linear Gadolinium-Based Contrast Agents
1.2.3 Macrocycle Gadolinium-Based Contrast Agents
1.3 Gadolinium-Based Contrast Agents Segment by Application
1.3.1 Global Gadolinium-Based Contrast Agents Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Specialist Clinic
1.3.4 Others
1.4 Global Gadolinium-Based Contrast Agents Market Size Estimates and Forecasts
1.4.1 Global Gadolinium-Based Contrast Agents Revenue 2019-2030
1.4.2 Global Gadolinium-Based Contrast Agents Sales 2019-2030
1.4.3 Global Gadolinium-Based Contrast Agents Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Gadolinium-Based Contrast Agents Market Competition by Manufacturers
2.1 Global Gadolinium-Based Contrast Agents Sales Market Share by Manufacturers (2019-2024)
2.2 Global Gadolinium-Based Contrast Agents Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Gadolinium-Based Contrast Agents Average Price by Manufacturers (2019-2024)
2.4 Global Gadolinium-Based Contrast Agents Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gadolinium-Based Contrast Agents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gadolinium-Based Contrast Agents, Product Type & Application
2.7 Gadolinium-Based Contrast Agents Market Competitive Situation and Trends
2.7.1 Gadolinium-Based Contrast Agents Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gadolinium-Based Contrast Agents Players Market Share by Revenue
2.7.3 Global Gadolinium-Based Contrast Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gadolinium-Based Contrast Agents Retrospective Market Scenario by Region
3.1 Global Gadolinium-Based Contrast Agents Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Gadolinium-Based Contrast Agents Global Gadolinium-Based Contrast Agents Sales by Region: 2019-2030
3.2.1 Global Gadolinium-Based Contrast Agents Sales by Region: 2019-2024
3.2.2 Global Gadolinium-Based Contrast Agents Sales by Region: 2025-2030
3.3 Global Gadolinium-Based Contrast Agents Global Gadolinium-Based Contrast Agents Revenue by Region: 2019-2030
3.3.1 Global Gadolinium-Based Contrast Agents Revenue by Region: 2019-2024
3.3.2 Global Gadolinium-Based Contrast Agents Revenue by Region: 2025-2030
3.4 North America Gadolinium-Based Contrast Agents Market Facts & Figures by Country
3.4.1 North America Gadolinium-Based Contrast Agents Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Gadolinium-Based Contrast Agents Sales by Country (2019-2030)
3.4.3 North America Gadolinium-Based Contrast Agents Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gadolinium-Based Contrast Agents Market Facts & Figures by Country
3.5.1 Europe Gadolinium-Based Contrast Agents Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Gadolinium-Based Contrast Agents Sales by Country (2019-2030)
3.5.3 Europe Gadolinium-Based Contrast Agents Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gadolinium-Based Contrast Agents Market Facts & Figures by Country
3.6.1 Asia Pacific Gadolinium-Based Contrast Agents Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Gadolinium-Based Contrast Agents Sales by Country (2019-2030)
3.6.3 Asia Pacific Gadolinium-Based Contrast Agents Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Gadolinium-Based Contrast Agents Market Facts & Figures by Country
3.7.1 Latin America Gadolinium-Based Contrast Agents Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Gadolinium-Based Contrast Agents Sales by Country (2019-2030)
3.7.3 Latin America Gadolinium-Based Contrast Agents Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gadolinium-Based Contrast Agents Market Facts & Figures by Country
3.8.1 Middle East and Africa Gadolinium-Based Contrast Agents Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Gadolinium-Based Contrast Agents Sales by Country (2019-2030)
3.8.3 Middle East and Africa Gadolinium-Based Contrast Agents Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gadolinium-Based Contrast Agents Sales by Type (2019-2030)
4.1.1 Global Gadolinium-Based Contrast Agents Sales by Type (2019-2024)
4.1.2 Global Gadolinium-Based Contrast Agents Sales by Type (2025-2030)
4.1.3 Global Gadolinium-Based Contrast Agents Sales Market Share by Type (2019-2030)
4.2 Global Gadolinium-Based Contrast Agents Revenue by Type (2019-2030)
4.2.1 Global Gadolinium-Based Contrast Agents Revenue by Type (2019-2024)
4.2.2 Global Gadolinium-Based Contrast Agents Revenue by Type (2025-2030)
4.2.3 Global Gadolinium-Based Contrast Agents Revenue Market Share by Type (2019-2030)
4.3 Global Gadolinium-Based Contrast Agents Price by Type (2019-2030)
5 Segment by Application
5.1 Global Gadolinium-Based Contrast Agents Sales by Application (2019-2030)
5.1.1 Global Gadolinium-Based Contrast Agents Sales by Application (2019-2024)
5.1.2 Global Gadolinium-Based Contrast Agents Sales by Application (2025-2030)
5.1.3 Global Gadolinium-Based Contrast Agents Sales Market Share by Application (2019-2030)
5.2 Global Gadolinium-Based Contrast Agents Revenue by Application (2019-2030)
5.2.1 Global Gadolinium-Based Contrast Agents Revenue by Application (2019-2024)
5.2.2 Global Gadolinium-Based Contrast Agents Revenue by Application (2025-2030)
5.2.3 Global Gadolinium-Based Contrast Agents Revenue Market Share by Application (2019-2030)
5.3 Global Gadolinium-Based Contrast Agents Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GE Healthcare
6.1.1 GE Healthcare Corporation Information
6.1.2 GE Healthcare Description and Business Overview
6.1.3 GE Healthcare Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GE Healthcare Gadolinium-Based Contrast Agents Product Portfolio
6.1.5 GE Healthcare Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Gadolinium-Based Contrast Agents Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Bracco Imaging
6.3.1 Bracco Imaging Corporation Information
6.3.2 Bracco Imaging Description and Business Overview
6.3.3 Bracco Imaging Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bracco Imaging Gadolinium-Based Contrast Agents Product Portfolio
6.3.5 Bracco Imaging Recent Developments/Updates
6.4 Guerbet Group
6.4.1 Guerbet Group Corporation Information
6.4.2 Guerbet Group Description and Business Overview
6.4.3 Guerbet Group Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Guerbet Group Gadolinium-Based Contrast Agents Product Portfolio
6.4.5 Guerbet Group Recent Developments/Updates
6.5 Hengrui Medicine
6.5.1 Hengrui Medicine Corporation Information
6.5.2 Hengrui Medicine Description and Business Overview
6.5.3 Hengrui Medicine Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hengrui Medicine Gadolinium-Based Contrast Agents Product Portfolio
6.5.5 Hengrui Medicine Recent Developments/Updates
6.6 Lantheus
6.6.1 Lantheus Corporation Information
6.6.2 Lantheus Description and Business Overview
6.6.3 Lantheus Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Lantheus Gadolinium-Based Contrast Agents Product Portfolio
6.6.5 Lantheus Recent Developments/Updates
6.7 YRPG
6.6.1 YRPG Corporation Information
6.6.2 YRPG Description and Business Overview
6.6.3 YRPG Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.4.4 YRPG Gadolinium-Based Contrast Agents Product Portfolio
6.7.5 YRPG Recent Developments/Updates
6.8 BeiLu Pharma
6.8.1 BeiLu Pharma Corporation Information
6.8.2 BeiLu Pharma Description and Business Overview
6.8.3 BeiLu Pharma Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.8.4 BeiLu Pharma Gadolinium-Based Contrast Agents Product Portfolio
6.8.5 BeiLu Pharma Recent Developments/Updates
6.9 Jiangsu Hengrui Medicine
6.9.1 Jiangsu Hengrui Medicine Corporation Information
6.9.2 Jiangsu Hengrui Medicine Description and Business Overview
6.9.3 Jiangsu Hengrui Medicine Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Jiangsu Hengrui Medicine Gadolinium-Based Contrast Agents Product Portfolio
6.9.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.10 Marotrast
6.10.1 Marotrast Corporation Information
6.10.2 Marotrast Description and Business Overview
6.10.3 Marotrast Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Marotrast Gadolinium-Based Contrast Agents Product Portfolio
6.10.5 Marotrast Recent Developments/Updates
6.11 Agfa
6.11.1 Agfa Corporation Information
6.11.2 Agfa Gadolinium-Based Contrast Agents Description and Business Overview
6.11.3 Agfa Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Agfa Gadolinium-Based Contrast Agents Product Portfolio
6.11.5 Agfa Recent Developments/Updates
6.12 Stary
6.12.1 Stary Corporation Information
6.12.2 Stary Gadolinium-Based Contrast Agents Description and Business Overview
6.12.3 Stary Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Stary Gadolinium-Based Contrast Agents Product Portfolio
6.12.5 Stary Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gadolinium-Based Contrast Agents Industry Chain Analysis
7.2 Gadolinium-Based Contrast Agents Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gadolinium-Based Contrast Agents Production Mode & Process
7.4 Gadolinium-Based Contrast Agents Sales and Marketing
7.4.1 Gadolinium-Based Contrast Agents Sales Channels
7.4.2 Gadolinium-Based Contrast Agents Distributors
7.5 Gadolinium-Based Contrast Agents Customers
8 Gadolinium-Based Contrast Agents Market Dynamics
8.1 Gadolinium-Based Contrast Agents Industry Trends
8.2 Gadolinium-Based Contrast Agents Market Drivers
8.3 Gadolinium-Based Contrast Agents Market Challenges
8.4 Gadolinium-Based Contrast Agents Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Gadolinium-Based Contrast Agents Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Gadolinium-Based Contrast Agents Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Gadolinium-Based Contrast Agents Market Competitive Situation by Manufacturers in 2023
Table 4. Global Gadolinium-Based Contrast Agents Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Gadolinium-Based Contrast Agents Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Gadolinium-Based Contrast Agents Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Gadolinium-Based Contrast Agents Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Gadolinium-Based Contrast Agents Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Gadolinium-Based Contrast Agents, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Gadolinium-Based Contrast Agents, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Gadolinium-Based Contrast Agents, Product Type & Application
Table 12. Global Key Manufacturers of Gadolinium-Based Contrast Agents, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gadolinium-Based Contrast Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gadolinium-Based Contrast Agents as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gadolinium-Based Contrast Agents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Gadolinium-Based Contrast Agents Sales by Region (2019-2024) & (K Units)
Table 18. Global Gadolinium-Based Contrast Agents Sales Market Share by Region (2019-2024)
Table 19. Global Gadolinium-Based Contrast Agents Sales by Region (2025-2030) & (K Units)
Table 20. Global Gadolinium-Based Contrast Agents Sales Market Share by Region (2025-2030)
Table 21. Global Gadolinium-Based Contrast Agents Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Gadolinium-Based Contrast Agents Revenue Market Share by Region (2019-2024)
Table 23. Global Gadolinium-Based Contrast Agents Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Gadolinium-Based Contrast Agents Revenue Market Share by Region (2025-2030)
Table 25. North America Gadolinium-Based Contrast Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Gadolinium-Based Contrast Agents Sales by Country (2019-2024) & (K Units)
Table 27. North America Gadolinium-Based Contrast Agents Sales by Country (2025-2030) & (K Units)
Table 28. North America Gadolinium-Based Contrast Agents Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Gadolinium-Based Contrast Agents Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Gadolinium-Based Contrast Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Gadolinium-Based Contrast Agents Sales by Country (2019-2024) & (K Units)
Table 32. Europe Gadolinium-Based Contrast Agents Sales by Country (2025-2030) & (K Units)
Table 33. Europe Gadolinium-Based Contrast Agents Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Gadolinium-Based Contrast Agents Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Gadolinium-Based Contrast Agents Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Gadolinium-Based Contrast Agents Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Gadolinium-Based Contrast Agents Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Gadolinium-Based Contrast Agents Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Gadolinium-Based Contrast Agents Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Gadolinium-Based Contrast Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Gadolinium-Based Contrast Agents Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Gadolinium-Based Contrast Agents Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Gadolinium-Based Contrast Agents Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Gadolinium-Based Contrast Agents Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Gadolinium-Based Contrast Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Gadolinium-Based Contrast Agents Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Gadolinium-Based Contrast Agents Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Gadolinium-Based Contrast Agents Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Gadolinium-Based Contrast Agents Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Gadolinium-Based Contrast Agents Sales (K Units) by Type (2019-2024)
Table 51. Global Gadolinium-Based Contrast Agents Sales (K Units) by Type (2025-2030)
Table 52. Global Gadolinium-Based Contrast Agents Sales Market Share by Type (2019-2024)
Table 53. Global Gadolinium-Based Contrast Agents Sales Market Share by Type (2025-2030)
Table 54. Global Gadolinium-Based Contrast Agents Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Gadolinium-Based Contrast Agents Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Gadolinium-Based Contrast Agents Revenue Market Share by Type (2019-2024)
Table 57. Global Gadolinium-Based Contrast Agents Revenue Market Share by Type (2025-2030)
Table 58. Global Gadolinium-Based Contrast Agents Price (USD/Unit) by Type (2019-2024)
Table 59. Global Gadolinium-Based Contrast Agents Price (USD/Unit) by Type (2025-2030)
Table 60. Global Gadolinium-Based Contrast Agents Sales (K Units) by Application (2019-2024)
Table 61. Global Gadolinium-Based Contrast Agents Sales (K Units) by Application (2025-2030)
Table 62. Global Gadolinium-Based Contrast Agents Sales Market Share by Application (2019-2024)
Table 63. Global Gadolinium-Based Contrast Agents Sales Market Share by Application (2025-2030)
Table 64. Global Gadolinium-Based Contrast Agents Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Gadolinium-Based Contrast Agents Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Gadolinium-Based Contrast Agents Revenue Market Share by Application (2019-2024)
Table 67. Global Gadolinium-Based Contrast Agents Revenue Market Share by Application (2025-2030)
Table 68. Global Gadolinium-Based Contrast Agents Price (USD/Unit) by Application (2019-2024)
Table 69. Global Gadolinium-Based Contrast Agents Price (USD/Unit) by Application (2025-2030)
Table 70. GE Healthcare Corporation Information
Table 71. GE Healthcare Description and Business Overview
Table 72. GE Healthcare Gadolinium-Based Contrast Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. GE Healthcare Gadolinium-Based Contrast Agents Product
Table 74. GE Healthcare Recent Developments/Updates
Table 75. Bayer Corporation Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Gadolinium-Based Contrast Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Bayer Gadolinium-Based Contrast Agents Product
Table 79. Bayer Recent Developments/Updates
Table 80. Bracco Imaging Corporation Information
Table 81. Bracco Imaging Description and Business Overview
Table 82. Bracco Imaging Gadolinium-Based Contrast Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Bracco Imaging Gadolinium-Based Contrast Agents Product
Table 84. Bracco Imaging Recent Developments/Updates
Table 85. Guerbet Group Corporation Information
Table 86. Guerbet Group Description and Business Overview
Table 87. Guerbet Group Gadolinium-Based Contrast Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Guerbet Group Gadolinium-Based Contrast Agents Product
Table 89. Guerbet Group Recent Developments/Updates
Table 90. Hengrui Medicine Corporation Information
Table 91. Hengrui Medicine Description and Business Overview
Table 92. Hengrui Medicine Gadolinium-Based Contrast Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Hengrui Medicine Gadolinium-Based Contrast Agents Product
Table 94. Hengrui Medicine Recent Developments/Updates
Table 95. Lantheus Corporation Information
Table 96. Lantheus Description and Business Overview
Table 97. Lantheus Gadolinium-Based Contrast Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Lantheus Gadolinium-Based Contrast Agents Product
Table 99. Lantheus Recent Developments/Updates
Table 100. YRPG Corporation Information
Table 101. YRPG Description and Business Overview
Table 102. YRPG Gadolinium-Based Contrast Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. YRPG Gadolinium-Based Contrast Agents Product
Table 104. YRPG Recent Developments/Updates
Table 105. BeiLu Pharma Corporation Information
Table 106. BeiLu Pharma Description and Business Overview
Table 107. BeiLu Pharma Gadolinium-Based Contrast Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. BeiLu Pharma Gadolinium-Based Contrast Agents Product
Table 109. BeiLu Pharma Recent Developments/Updates
Table 110. Jiangsu Hengrui Medicine Corporation Information
Table 111. Jiangsu Hengrui Medicine Description and Business Overview
Table 112. Jiangsu Hengrui Medicine Gadolinium-Based Contrast Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Jiangsu Hengrui Medicine Gadolinium-Based Contrast Agents Product
Table 114. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 115. Marotrast Corporation Information
Table 116. Marotrast Description and Business Overview
Table 117. Marotrast Gadolinium-Based Contrast Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Marotrast Gadolinium-Based Contrast Agents Product
Table 119. Marotrast Recent Developments/Updates
Table 120. Agfa Corporation Information
Table 121. Agfa Description and Business Overview
Table 122. Agfa Gadolinium-Based Contrast Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Agfa Gadolinium-Based Contrast Agents Product
Table 124. Agfa Recent Developments/Updates
Table 125. Stary Corporation Information
Table 126. Stary Description and Business Overview
Table 127. Stary Gadolinium-Based Contrast Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Stary Gadolinium-Based Contrast Agents Product
Table 129. Stary Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Gadolinium-Based Contrast Agents Distributors List
Table 133. Gadolinium-Based Contrast Agents Customers List
Table 134. Gadolinium-Based Contrast Agents Market Trends
Table 135. Gadolinium-Based Contrast Agents Market Drivers
Table 136. Gadolinium-Based Contrast Agents Market Challenges
Table 137. Gadolinium-Based Contrast Agents Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Gadolinium-Based Contrast Agents
Figure 2. Global Gadolinium-Based Contrast Agents Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Gadolinium-Based Contrast Agents Market Share by Type in 2023 & 2030
Figure 4. Linear Gadolinium-Based Contrast Agents Product Picture
Figure 5. Macrocycle Gadolinium-Based Contrast Agents Product Picture
Figure 6. Global Gadolinium-Based Contrast Agents Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Gadolinium-Based Contrast Agents Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Specialist Clinic
Figure 10. Others
Figure 11. Global Gadolinium-Based Contrast Agents Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Gadolinium-Based Contrast Agents Market Size (2019-2030) & (US$ Million)
Figure 13. Global Gadolinium-Based Contrast Agents Sales (2019-2030) & (K Units)
Figure 14. Global Gadolinium-Based Contrast Agents Average Price (USD/Unit) & (2019-2030)
Figure 15. Gadolinium-Based Contrast Agents Report Years Considered
Figure 16. Gadolinium-Based Contrast Agents Sales Share by Manufacturers in 2023
Figure 17. Global Gadolinium-Based Contrast Agents Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Gadolinium-Based Contrast Agents Players: Market Share by Revenue in 2023
Figure 19. Gadolinium-Based Contrast Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Gadolinium-Based Contrast Agents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Gadolinium-Based Contrast Agents Sales Market Share by Country (2019-2030)
Figure 22. North America Gadolinium-Based Contrast Agents Revenue Market Share by Country (2019-2030)
Figure 23. United States Gadolinium-Based Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Gadolinium-Based Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Gadolinium-Based Contrast Agents Sales Market Share by Country (2019-2030)
Figure 26. Europe Gadolinium-Based Contrast Agents Revenue Market Share by Country (2019-2030)
Figure 27. Germany Gadolinium-Based Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Gadolinium-Based Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Gadolinium-Based Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Gadolinium-Based Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Gadolinium-Based Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Gadolinium-Based Contrast Agents Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Gadolinium-Based Contrast Agents Revenue Market Share by Region (2019-2030)
Figure 34. China Gadolinium-Based Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Gadolinium-Based Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Gadolinium-Based Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Gadolinium-Based Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Gadolinium-Based Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Gadolinium-Based Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Gadolinium-Based Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Gadolinium-Based Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Gadolinium-Based Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Gadolinium-Based Contrast Agents Sales Market Share by Country (2019-2030)
Figure 44. Latin America Gadolinium-Based Contrast Agents Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Gadolinium-Based Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Gadolinium-Based Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Gadolinium-Based Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Gadolinium-Based Contrast Agents Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Gadolinium-Based Contrast Agents Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Gadolinium-Based Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Gadolinium-Based Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Gadolinium-Based Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Gadolinium-Based Contrast Agents by Type (2019-2030)
Figure 54. Global Revenue Market Share of Gadolinium-Based Contrast Agents by Type (2019-2030)
Figure 55. Global Gadolinium-Based Contrast Agents Price (USD/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Gadolinium-Based Contrast Agents by Application (2019-2030)
Figure 57. Global Revenue Market Share of Gadolinium-Based Contrast Agents by Application (2019-2030)
Figure 58. Global Gadolinium-Based Contrast Agents Price (USD/Unit) by Application (2019-2030)
Figure 59. Gadolinium-Based Contrast Agents Value Chain
Figure 60. Gadolinium-Based Contrast Agents Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
